Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potency of Cat Epithelial Allergenic Extracts
NCT01740024Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Nov 2012
- Primary completion
- Dec 2013
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of depigmented cat epithelial allergenic extract in cat allergy, sponsored by LETI Pharma. Started Nov 2012; status: completed.
02
Drugs
depigmented cat epithelial allergenic extract
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT01740024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740024.